Live feed20:30:12·522dINSIDERFilingvia QuantisnowVP of Research and Development Murali Ramachandran bought $318 worth of shares (200 units at $1.59), increasing direct ownership by 0.15% to 133,057 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.KAPA· Kairos Pharma Ltd.Health CareOriginal source